137 related articles for article (PubMed ID: 32832407)
1. Prevalence of cryptococcal antigen (CrAg) among HIV-positive patients in Eswatini, 2014-2015.
Haumba SM; Toda M; Jeffries R; Ehrenkranz P; Pasipamire M; Ao T; Lukhele N; Mazibuko S; Mkhontfo M; Smith RM; Chiller T
Afr J Lab Med; 2020; 9(1):933. PubMed ID: 32832407
[TBL] [Abstract][Full Text] [Related]
2. Cryptococcal antigen prevalence in HIV-infected Tanzanians: a cross-sectional study and evaluation of a point-of-care lateral flow assay.
Rugemalila J; Maro VP; Kapanda G; Ndaro AJ; Jarvis JN
Trop Med Int Health; 2013 Sep; 18(9):1075-1079. PubMed ID: 23937699
[TBL] [Abstract][Full Text] [Related]
3. Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil.
Vidal JE; Toniolo C; Paulino A; Colombo A; Dos Anjos Martins M; da Silva Meira C; Pereira-Chioccola VL; Figueiredo-Mello C; Barros T; Duarte J; Fonseca F; Alves Cunha M; Mendes C; Ribero T; Dos Santos Lazera M; Rajasingham R; Boulware DR
Trop Med Int Health; 2016 Dec; 21(12):1539-1544. PubMed ID: 27699970
[TBL] [Abstract][Full Text] [Related]
4. Implementation of point-of-care testing and prevalence of cryptococcal antigenaemia among patients with advanced HIV disease in Mumbai, India.
Acharya S; Allam RR; Karanjkar VK; Rathod D; Mahajan R; Deshpande P; Palkar A; Todmal S; Koli S; Dhande S; Dale J; Yeldandi VV; Harshana A; Agarwal R; Upadhyaya S; Nyendak M
BMJ Open; 2023 Jun; 13(6):e070500. PubMed ID: 37349096
[TBL] [Abstract][Full Text] [Related]
5. Validation of clinic-based cryptococcal antigen lateral flow assay screening in HIV-infected adults in South Africa.
Drain PK; Hong T; Krows M; Govere S; Thulare H; Wallis CL; Gosnell BI; Moosa MY; Bassett IV; Celum C
Sci Rep; 2019 Feb; 9(1):2687. PubMed ID: 30804356
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Accuracy of Point of Care Cryptococcal Antigen Lateral Flow Assay in Fingerprick Whole Blood and Urine Samples for the Detection of Asymptomatic Cryptococcal Disease in Patients with Advanced HIV Disease.
Boyd K; Kouamou V; Hlupeni A; Tangwena Z; Ndhlovu CE; Makadzange AT;
Microbiol Spectr; 2022 Aug; 10(4):e0107522. PubMed ID: 35924841
[TBL] [Abstract][Full Text] [Related]
7. Prospective cohort of AIDS patients screened for cryptococcal antigenaemia, pre-emptively treated and followed in Brazil.
Borges MASB; de Araújo Filho JA; Oliveira BJS; Moreira IS; de Paula VV; de Bastos AL; Soares RBA; Turchi MD
PLoS One; 2019; 14(7):e0219928. PubMed ID: 31344140
[TBL] [Abstract][Full Text] [Related]
8. Establishing a cost-per-result of laboratory-based, reflex Cryptococcal antigenaemia screening (CrAg) in HIV+ patients with CD4 counts less than 100 cells/μl using a Lateral Flow Assay (LFA) at a typical busy CD4 laboratory in South Africa.
Cassim N; Schnippel K; Coetzee LM; Glencross DK
PLoS One; 2017; 12(2):e0171675. PubMed ID: 28166254
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of cryptococcal antigenaemia amongst asymptomatic advanced HIV patients in Pune, India.
Kadam D; Chandanwale A; Bharadwaj R; Nevrekar N; Joshi S; Patil S; Gupte N; Sangle S; Chopade K; Kulkarni V; Balasubramanian U; Suryavanshi N; Jain D; Kanade S; Dharmashale S; Kagal A; Gupta A; Mave V
Indian J Med Microbiol; 2017; 35(1):105-108. PubMed ID: 28303828
[TBL] [Abstract][Full Text] [Related]
10. Implementation of tuberculosis and cryptococcal meningitis rapid diagnostic tests amongst patients with advanced HIV at Kamuzu Central Hospital, Malawi, 2016-2017.
Kanyama C; Chagomerana MB; Chawinga C; Ngoma J; Shumba I; Kumwenda W; Armando B; Kumwenda T; Kumwenda E; Hosseinipour MC
BMC Infect Dis; 2022 Mar; 22(1):224. PubMed ID: 35247971
[TBL] [Abstract][Full Text] [Related]
11. Cryptococcal antigen screening by lay cadres using a rapid test at the point of care: A feasibility study in rural Lesotho.
Rick F; Niyibizi AA; Shroufi A; Onami K; Steele SJ; Kuleile M; Muleya I; Chiller T; Walker T; Van Cutsem G
PLoS One; 2017; 12(9):e0183656. PubMed ID: 28877182
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease.
Tenforde MW; Boyer-Chammard T; Muthoga C; Tawe L; Milton T; Rulaganyang I; Lechiile K; Rukasha I; Leeme TB; Govender NP; Ngidi J; Mine M; Molloy SF; Harrison TS; Lortholary O; Jarvis JN
J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33087436
[TBL] [Abstract][Full Text] [Related]
13. Cryptococcal Antigen Screening in Asymptomatic HIV-Infected Antiretroviral Naïve Patients in Cameroon and Evaluation of the New Semi-Quantitative Biosynex CryptoPS Test.
Temfack E; Kouanfack C; Mossiang L; Loyse A; Fonkoua MC; Molloy SF; Koulla-Shiro S; Delaporte E; Dromer F; Harrison T; Lortholary O
Front Microbiol; 2018; 9():409. PubMed ID: 29593675
[No Abstract] [Full Text] [Related]
14. Estimated Prevalence of Cryptococcus Antigenemia (CrAg) among HIV-Infected Adults with Advanced Immunosuppression in Namibia Justifies Routine Screening and Preemptive Treatment.
Sawadogo S; Makumbi B; Purfield A; Ndjavera C; Mutandi G; Maher A; Kaindjee-Tjituka F; Kaplan JE; Park BJ; Lowrance DW
PLoS One; 2016; 11(10):e0161830. PubMed ID: 27760140
[TBL] [Abstract][Full Text] [Related]
15. Estimating the cost-per-result of a national reflexed Cryptococcal antigenaemia screening program: Forecasting the impact of potential HIV guideline changes and treatment goals.
Cassim N; Coetzee LM; Schnippel K; Glencross DK
PLoS One; 2017; 12(8):e0182154. PubMed ID: 28829788
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of point of care serum cryptococcal antigen by lateral flow immunoassay for diagnosis of cryptococcosis and cryptococcal meningitis in HIV-positive patients.
Kamble U; Dheeresh KH; Bhosale K; Indu MB; Sharma B; Chowdhary A
Indian J Sex Transm Dis AIDS; 2021; 42(1):14-18. PubMed ID: 34765932
[TBL] [Abstract][Full Text] [Related]
17. Performance of cryptococcal antigen lateral flow assay in serum, cerebrospinal fluid, whole blood, and urine in HIV-infected patients with culture-proven cryptococcal meningitis admitted at a Brazilian referral center.
Vidal JE; Toniolo C; Paulino A; Colombo AL; Martins MDA; Meira CDS; Azevedo RGS; Pereira-Chioccola VL; Gomes HR; Lazera MDS; Oliveira ACP; Boulware DR
Rev Inst Med Trop Sao Paulo; 2018; 60():e1. PubMed ID: 29451598
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of Cryptococcal antigenemia using a finger-prick lateral flow assay in individuals with advanced HIV disease in Santarém Municipality, Brazilian Amazon Basin.
Assy JGPL; Said RDC; Pinheiro OC; Brandão ADS; Boulware DR; França FOS; Vidal JE
Med Mycol; 2021 Sep; 59(9):909-915. PubMed ID: 33908611
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and mortality of cryptococcal disease in adults with advanced HIV in an urban tertiary hospital in Sierra Leone: a prospective study.
Lakoh S; Rickman H; Sesay M; Kenneh S; Burke R; Baldeh M; Jiba DF; Tejan YS; Boyle S; Koroma C; Deen GF; Beynon F
BMC Infect Dis; 2020 Feb; 20(1):141. PubMed ID: 32059703
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis.
Rajasingham R; Meya DB; Greene GS; Jordan A; Nakawuka M; Chiller TM; Boulware DR; Larson BA
PLoS One; 2019; 14(1):e0210105. PubMed ID: 30629619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
